⚠ BETA — all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 13, 2026
The Dispatch

NSE

Indo Borax & ChemicalsINDOBORAX

Indo Borax & Chemicals (INDOBORAX) is an NSE-listed company. This page brings together its recent bulk & block deals, AI-scored exchange filings and corporate actions.

Net institutional flow

No institutional deals

Institutional buyers

0 in / 0 out

High-impact filings

1 · tilt Bullish

Next corporate action

—

Filings that matter

  • 1
    ComplianceNeutral

    Financial statements revised for the fiscal year ending March 2026. • No specific changes or impacts mentioned. Impact: 1/10 · Neutral

  • 1
    ComplianceNeutral

    Financial statements revised for the fiscal year ending March 2026. • No specific changes or impacts mentioned. Impact: 1/10 · Neutral

  • 3
    GeneralNeutral

    The National Company Law Tribunal (NCLT) has directed that meetings of equity shareholders and unsecured creditors of Indo Thai Securities Limited be convened within 45 days to approve a demerger scheme. - These meetings are necessary steps

    Source PDF →
  • 1
    ComplianceNeutral

    Financial statements revised for the financial year ending March 2026. • No specific changes or impacts mentioned. Impact: 1/10 · Neutral

  • 1
    ComplianceNeutral

    Financial statements revised for the fiscal year ending March 2026. • No specific changes or impacts mentioned. Impact: 1/10 · Neutral

  • 1
    ComplianceNeutral

    Financial statements revised for the financial year ending March 2026. • No specific changes or impacts mentioned. Impact: 1/10 · Neutral

  • 1
    ComplianceNeutral

    Financial statements revised for the fiscal year ending March 2026. • No specific financial impacts or changes mentioned. Impact: 1/10 · Neutral

  • 7
    ResultsBullish

    The company reported 23% growth in operating revenue and 18% growth in net profit for FY2026. - A special dividend of Rs. 30 per equity share was announced, representing an additional one-time reward. Impact: 7/10 · Bullish

    Source PDF →
  • 2
    Meet / ConcallNeutral

    Meeting scheduled with analysts and institutional investors. - Company updates on financial performance and strategy discussed. Impact: 2/10 · Neutral

Bulk & block deals

No recent bulk/block deals for INDOBORAX.

Results & transcripts

Calls & transcripts

  • Aurobindo Pharma Limited